公司新闻(英文)
May 8, 2018 / 11:28 AM / 9 months ago

BRIEF-Zynerba Pharmaceuticals Reports Q1 Loss Of $0.91 Per Share

1 分钟阅读

May 8 (Reuters) - Zynerba Pharmaceuticals Inc:

* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* ZYNERBA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.91

* ZYNERBA - BELIEVES CASH, CASH EQUIVALENT POSITION OF $52.1 MILLION AS OF MARCH 31, IS SUFFICIENT TO FUND OPERATIONS, CAPITAL REQUIREMENTS INTO 2019 Source text: (bit.ly/2IqdNOw) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

我们的标准：汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below